SAB BIOTHERAPEUTICS INC (SABS) Stock Balance Sheet
NASDAQ:SABS - Nasdaq - US78397T2024 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 80.00K | |||
| Cash Equivalents | 9.17M | 56.57M | 15.05M | 33.21M | 12.61M | |||
| Marketable Securities | 21.23M | N/A | N/A | N/A | N/A | |||
| Receivables | 97.05K | 0.00 | 5.56M | 8.01M | 20.57M | |||
| Other Current Assets | 2.04M | 2.34M | 1.49M | 8.97M | 1.27M | |||
| Total Current Assets | 32.54M | 58.91M | 22.10M | 50.19M | 34.45M | |||
| Non-Current Assets | ||||||||
| PPE Net | 20.75M | 24.68M | 28.34M | 30.95M | 22.08M | |||
| Other Non-Current Assets | 514.41K | 350.00K | 468.00K | 0.00 | 240.00K | |||
| Total Non-Current Assets | 21.26M | 25.03M | 28.81M | 30.95M | 22.08M | |||
| TOTAL ASSETS | 53.80M | 83.94M | 50.91M | 81.14M | 56.54M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 139.85K | 1.18M | 905.00K | 1.96M | 733.00K | |||
| Accrued Expenses | 6.52M | 7.32M | 10.36M | 13.38M | 2.83M | |||
| Accounts Payable | 1.30M | 946.00K | 3.68M | 4.46M | 7.38M | |||
| Other Current Liabilities | 860.20K | 1.36M | 50.00K | 6.66M | 117.00K | |||
| Total Current Liabilities | 8.82M | 10.81M | 14.99M | 26.45M | 11.06M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 3.31M | 3.42M | 4.17M | 3.76M | 4.10M | |||
| Other Non-Current Liabilities | 4.77M | 12.41M | 682.00K | 12.37M | 2.37M | |||
| Total Non-Current Liabilities | 8.08M | 15.83M | 4.85M | 16.14M | 6.47M | |||
| TOTAL LIABILITIES | 16.89M | 26.64M | 19.85M | 42.59M | 17.53M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -112.77M | -90.06M | -47.87M | -29.13M | -11.98M | |||
| Additional Paid In Capital | 155.14M | 152.86M | 84.44M | 67.67M | 50.99M | |||
| Common Shares | 940.00 | 1.00K | 5.00K | 4.00K | 3.00K | |||
| Treasury Stock | -5.52M | -5.52M | -5.52M | 0.00 | N/A | |||
| Other Shareholders' Equity | 52.13K | 26.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 9.23M | 9.22M | 5.04M | 4.35M | 2.60M | |||
| Tangible Book Value per Share | 4.00 | 6.21 | 6.16 | 8.86 | 15.02 | |||
| Total Shareholders' Equity | 36.90M | 57.30M | 31.06M | 38.55M | 39.01M | |||
| TOTAL LIABILITIES AND EQUITY | 53.80M | 83.94M | 50.91M | 81.14M | 56.54M | |||
| Statistics | ||||||||
| Debt/Equity | 0.09 | 0.06 | 0.13 | 0.10 | 0.11 | |||
| Current Ratio | 3.69 | 5.45 | 1.47 | 1.90 | 3.11 | |||
| Return On Assets (ROA) | -84.70% | -50.27% | -36.82% | -21.13% | 35.58% | |||
| Return On Equity (ROE) | -123.48% | -73.64% | -60.34% | -44.47% | 51.57% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 35.71% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | 49.41% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | 49.41% | |||
All data in USD , ROIC based on taxRate of 0.21